Two Sigma Securities »

Achilles Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $13k 15k 0.89

More positions owned by Two Sigma Securities

Apple (AAPL)
Microsoft Corporation Call Option (MSFT)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Netflix (NFLX)
Advanced Micro Devices Call Option (AMD)
Boeing Company Call Option (BA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Johnson & Johnson Call Option (JNJ)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Broadcom Call Option (AVGO)

View all positions for Two Sigma Securities

Top funds holding Achilles Therapeutics

Syncona Portfolio
Fcpm Iii Services B.v.
Artal Group
Baker Bros. Advisors
Redmile Group
Point72 Asset Management
Citadel Advisors
Virtu Financial
Millennium Management
Bank of America Corporation
Two Sigma Securities
Global Retirement Partners
Jpmorgan Chase & Co
Royal Bank of Canada

View all funds holding Achilles Therapeutics